Clinical Trial Update: A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

This update describes a phase 1/2 clinical trial evaluating the combination of temsirolimus and sunitinib in adults with advanced renal cell carcinoma, which ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Sunitinib (sunitinib)
• Temsirolimus (temsirolimus)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Renal Cell Carcinoma | Phase 1, Phase 2 | Status: TERMINATED